Digital health pharma news from Q4 2016
Investment in digital tools to enhance data collection in clinical trials.
Litmus Health using wearable devices to test the effects of activity, sleep, and diet on Inflammatory Bowel Disease (IBD) patients.
VeriTrova biomarker analysis leveraging technology to reduce normal analysis time from months to weeks.
FDA cleared the wireless integration of LifeScan’s blood glucose monitoring systems and WellDoc’s digital diabetes management platform.
Senseonics working on a long-term implantable continuous glucose monitor called Eversense.